![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | EXP | | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RAP2C mRNA | CTD | PMID:24763279 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:1619982 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of RAP2C mRNA | CTD | PMID:22206623 | 1,3,5-trinitro-1,3,5-triazinane | decreases expression | ISO | RGD:1588562 | 6480464 | cyclonite results in decreased expression of RAP2C mRNA | CTD | PMID:25559034 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1619982 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1619982 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1619982 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RAP2C mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1588562 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RAP2C mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | RGD:1588562 | 6480464 | 2 more ... | CTD | PMID:32109520 | acetamide | decreases expression | ISO | RGD:1588562 | 6480464 | acetamide results in decreased expression of RAP2C mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | RGD:1588562 | 6480464 | Acrylamide results in increased expression of RAP2C mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of RAP2C gene | CTD | PMID:27153756 | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of RAP2C mRNA | CTD | PMID:20458559 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzoapyrene affects the methylation of RAP2C promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzoapyrene results in increased methylation of RAP2C 5' UTR | CTD | PMID:27901495 | bisphenol A | affects expression | ISO | RGD:1588562 | 6480464 | bisphenol A affects the expression of RAP2C mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:1588562 | 6480464 | bisphenol A results in increased expression of RAP2C mRNA | CTD | PMID:33296240 | choline | multiple interactions | ISO | RGD:1619982 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP2C gene | CTD | PMID:20938992 | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of RAP2C mRNA | CTD | PMID:19376846 | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of RAP2C mRNA | CTD | PMID:20458559 | dibutyl phthalate | decreases expression | ISO | RGD:1619982 | 6480464 | Dibutyl Phthalate results in decreased expression of RAP2C mRNA | CTD | PMID:21266533 | finasteride | increases expression | ISO | RGD:1588562 | 6480464 | Finasteride results in increased expression of RAP2C mRNA | CTD | PMID:24136188 | flutamide | increases expression | ISO | RGD:1588562 | 6480464 | Flutamide results in increased expression of RAP2C mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | ISO | RGD:1619982 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP2C gene | CTD | PMID:20938992 | L-methionine | multiple interactions | ISO | RGD:1619982 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RAP2C gene | CTD | PMID:20938992 | lead diacetate | multiple interactions | EXP | | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RAP2C mRNA | CTD | PMID:22839698 | paracetamol | affects expression | ISO | RGD:1619982 | 6480464 | Acetaminophen affects the expression of RAP2C mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RAP2C mRNA | CTD | PMID:21420995 | PCB138 | multiple interactions | ISO | RGD:1619982 | 6480464 | [2 more ... | CTD | PMID:25510870 | pirinixic acid | increases expression | ISO | RGD:1619982 | 6480464 | pirinixic acid results in increased expression of RAP2C mRNA | CTD | PMID:17426115 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of RAP2C mRNA | CTD | PMID:31533062 | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of RAP2C mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of RAP2C mRNA | CTD | PMID:25979313 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of RAP2C mRNA | CTD | PMID:23527032, PMID:24935251 | zinc protoporphyrin | multiple interactions | EXP | | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RAP2C mRNA | CTD | PMID:22839698 | |